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Purpose: To characterize the tear film peptidome and low molecular weight protein profiles of healthy control individuals,
and to evaluate changes due to day-to-day and individual variation and tear collection methods, by using solid phase
extraction coupled to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
profiling.
Methods: The tear protein profiles of six healthy volunteers were analyzed over seven days and inter-day and inter-
individual variability was evaluated. The bilaterality of tear film and the effect of tear collection methods on protein
profiles were also analyzed in some of these patients. MALDI-TOF MS analyses were performed on tear samples purified
by using a solid phase extraction (SPE) method based on C18 functionalized magnetic beads for peptide and low molecular
weight protein enrichment, focusing spectra acquisition on the 1 to 20 kDa range. Spectra were analyzed using principal
component analysis (PCA) with MultiExperiment Viewer (TMeV) software. Volunteers were examined in terms of tear
production status (Schirmer I test), clinical assessment of palpebral lids and meibomian glands, and a subjective OSD
questionnaire before tear collection by a glass micro-capillary.
Results: Analysis of peptides and proteins in the 1–20 kDa range showed no significant inter-day differences in tear
samples collected from six healthy individuals during seven days of monitoring, but revealed subtle intrinsic inter-
individual differences. Profile analyses of tears collected from the right and left eyes confirmed tear bilaterality in four
healthy patients. The addition of physiologic serum for tear sample collection did not affect the peptide and small protein
profiles with respect to the number of resolved peaks, but it did reduce the signal intensity of the peaks, and increased
variability. Magnetic beads were found to be a suitable method for tear film purification for the profiling study.
Conclusions: No significant variability in tear peptide and protein profiles below 20 kDa was found in healthy controls
over a seven day period, nor in right versus left eye profiles from the same individual. Subtle inter-individual differences
can be observed upon tear profiling analysis and confirm intrinsic variability between control subjects. Addition of
physiologic serum for tear collection affects the proteome and peptidome in terms of peak intensities, but not in the
composition of the profiles themselves. This work shows that MALDI-TOF MS coupled with C18 magnetic beads is an
effective and reproducible methodology for tear profiling studies in the clinical monitoring of patients.
Tear film is a complex gel mixture with a thickness of
between 6 µm and 20 µm. It is distributed on the ocular surface
and contains proteins, lipids, electrolytes, some small organic
molecules  and  metabolites  secreted  by  the  main  lacrimal
gland and the palpebral accessory glands [1-3]. The normal
tear volume is around 6 µl, with a mean secretion rate about
1.2 µl per min, and a turnover rate of approximately 16% per
min [4]. In spite of being similar to other body fluids in terms
of protein composition, tear film has a characteristically high
concentration of proteins (8 μg/μl approximately), ions and
antioxidant  compounds  [1,5],  which  makes  it  particularly
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suitable for proteomic analysis, despite the small volume of
the tear.
In the past, tear film proteins have been studied by using
gel  electrophoresis  and  other  techniques  such  as  Edman
degradation. These studies have revealed that the major tear
proteins include lysozyme, lactoferrin, lipocalin, tear specific
prealbumin,  serum  albumin,  secretory  IgA,  and  lipophilin
[6-10]. More recently, almost 500 different proteins have been
identified in the human tear film [5], although it has been
estimated that 70%–85% of total secretory protein can be
accounted  for  by  lipocalin,  lysozyme,  lactoferrin  and
secretory  immunoglobulin  A  [6,11].  The  concentration  of
these major tear film proteins can oscillate between 1.5 to
2.07  mg/ml.  However,  the  concentration  of  other  low
abundance tear film proteins is below 0.1 mg/ml [11].
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1572In  recent  years,  mass  spectrometry  (MS)  based
proteomics has been successfully used for the profiling study
of different body fluids, such as urine [12], serum [13], blood
plasma [14], and also tear [15]. This approach has several
advantages  over  other  proteomics  methods,  such  as  high
sensitivity  in  the  nanogram/picogram  range,  rapid
performance, and the possibility of analyzing both protein and
peptide  abundance  levels.  Previous  determinations  and
mapping of tear protein profiles have employed a variety of
mass spectrometry technologies, such as surface-enhanced
laser  desorption  ionization-  time  of  flight  (SELDI-TOF),
matrix  assisted  laser  desorption  ionization-time  of  flight
(MALDI-TOF)  and  liquid  chromatography  coupled  with
electrospray  ionization  (LC/MS)  [16-19].  In  particular,
MALDI-TOF  MS  has  been  used  to  characterize  low
molecular weight protein masses [20] in the range of 848–
3,897  Da,  finding  an  absence  of  diurnal  variation  of  low
molecular weight species in tears.
However, the contribution to variability in tear protein
studies by day-to-day and individual variability, as well as eye
bilaterality remains to be characterized. Additionally, it has
also  been  reported  that  differences  in  tear  proteome
information may arise from the method employed for tear
sample collection, such as Schirmer test papers or capillaries
[16,19]. Finally, it is currently unknown if the addition of
physiologic serum for tear collection in the eye-flush method
introduces additional variability in tear protein profiles with
respect to standard methods [21,22].
Thus, in the present work we have studied variation due
to tear sampling from the same individual on different days
(inter-day variation) and due to different individuals (inter-
individual variation), as well as variation due to sampling
from  different  eyes  of  the  same  individual  (inter-eye)  in
healthy  controls  using  the  standard  capillary  method.  In
addition, we evaluated differences in the tear film peptidome
and low molecular weight proteins (in the 1–20 kDa range)
measured by MALDI-TOF MS profiling due to capillary and
eye-flush collection methods. Tear samples were enriched
before  MALDI-TOF  MS  by  solid  phase  extraction  (SPE)
using reverse-phase affinity magnetic beads (C18) to enhance
both reproducibility and the overall quality of the analysis.
Finally,  data  exploratory  analysis  involving  Principal
Component Analysis (PCA) was used to interpret protein
profile  data  and  results  were  visualized  using
MultiExperiment  Viewer  (TMeV)  software  (Dana-Farber
Cancer Institute, Boston, MA) [23,24].
METHODS
Patient selection: The study was performed with 6 healthy
volunteers, two men (32.50±2.12 years), and four women
(33.75±10.24 years). The clinical characterization of these
participants was conducted by medically qualified personnel.
Written informed consent was obtained in accordance with
the declaration of Helsinki on Biomedical Research Involving
Human  Subjects.  Clinical  features  assessed  included
Schirmer test, examination of tear film stability, palpebral lids
and meibomian glands. To confirm the absence of subjective
symptoms, each patient was asked to fill out a modified Ocular
Surface Disease (OSD) questionnaire about burning, itching,
foreign body sensation, dryness and photophobia. Exclusion
criteria included ocular surgery (two months before), allergy
history, atopy, use of contact lenses, and administration of
corticoids or any medication.
Tear samples: Tear samples were collected with a 10 µl glass
microcapillary  (Micropipettes  Blaubrand,  Wertheim,
Germany) from six control volunteer individuals. For tear
sample collection, the microcapillary was placed close to the
temporal lid margin of the eye, taking special care not to touch
the conjunctiva.
To assess inter-day and inter-individual variability, tears
were collected from all six control subjects (CT1-CT6) over
seven  consecutive  workdays,  without  adding  any  type  of
lubricant or anesthesia (standard method). The bilaterality in
tear samples was assessed in four volunteers (CT1, CT3, CT4,
and CT6) from whom the tear sample was collected from both
eyes using the standard method the same day. To study the
effect of sample collection method on tear profiles, two weeks
later four control subjects (CT1, CT3, CT4, and CT6) were
selected  for  a  four  day  monitoring.  Each  day,  tears  were
collected  from  the  left  eye  (LE)  without  the  addition  of
physiologic serum (standard method), and from the right eye
(RE)  with  a  new  glass  microcapillary  following  previous
addition of a drop of physiologic serum (eye-flush method).
For  additional  studies,  a  tear  sample  from  CT5  was
collected to perform solid phase extraction (SPE) assays, and
additional tears from CT1 and CT2 were collected to verify
the reproducibility of the magnetic bead technique for tear
sample purification and enrichment.
Tear  samples  were  always  collected  between  13:00–
14:00 h, placed in 1.5 ml Protein LoBind Tubes (Eppendorf,
Hamburg,  Germany)  spun  down  to  remove  the  possible
cellular  debris  and  immediately  stored  at  −80  °C  until
analysis. Tear samples were always collected by the same
person, at the same time of the day, stored in the same type of
tubes, and identically subjected to a systematic protocol of
defreezing, processing and analysis, to minimize variability
in results due to handling.
Solid-phase  extraction  (SPE):  A  purification  step  was
included before MALDI-TOF MS analyses with the aim of
enriching tear samples in peptides and low molecular weight
proteins. We tested four reverse-phase based SPE methods:
commercial and customized tips as well as magnetic beads.
Two types of homemade microcolumns were prepared.
These consisted of Empore disks functionalized with octyl
(C8) or octadecyl (C18) groups (3M, St. Paul, MN). Disks
were manually inserted into pipette-tips. Commercial ZipTip
Pipette  Tips  (Millipore,  MA)  equipped  with  C18
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1573chromatographic  media  in  the  stationary  phase  were  also
tested.  Finally,  ferromagnetic  nanospheres  functionalized
with C18 from MB-HIC18 Magnetic Bead Purification Kit
(Bruker Daltonics, Bremen, Germany) were assessed.
In all cases, tear fluid samples were progressively thawed
on ice, and subsequently 1 µl of each sample was diluted to
10  µl  in  MilliQ  (Millipore,  Bedford,  MA)  quality  water.
Purifications with C8 and C18 Empore disk microcolumns
and ZipTips were performed by adding 5 µl of diluted samples
(1:10) to micro-columns, followed by a washing step with
10 µl 0.1% trifluoroacetic acid (TFA). Sample elution was
performed by adding 1 µl alpha-cyano-4-hydroxycinnamic
(HCCA) matrix in acetonitrile: 0.1% TFA (70:30). Magnetic
bead  based  purification  was  performed  according  to  the
protocol suggested by the manufacturer. After binding and
washing steps, each purified sample was eluted with 5 µl of
an ethanol:acetone (2:1) solution.
MALDI-TOF mass spectrometry: For mass spectrometry, all
tip  preparations  (Empore  C8,  C18,  and  Zip  Tips)  were
performed by the dried droplet method (0.5 µl sample+0.5 µl
HCCA matrix). In contrast, magnetic bead preparations were
diluted (1:10) in HCCA matrix. In all cases, 1 µl of each
diluted sample was spotted in quadruplicate onto an MTP
AnchorChip  600/384  TF  plate.  Profile  analyses  were
performed  on  an  Autoflex  III  TOF/TOF  Smartbeam
spectrometer in which the profiling data were acquired in
linear-mode  geometry,  using  the  following  settings:  ion
source 1, 6.02 kV; ion source 2, 5.32 kV; lens, 3.01 kV.
Ionization was achieved by irradiation with a solid state pulsed
laser, operating at 66 Hz (30% attenuator). All spectra were
obtained randomly over the spot surface (5,000 shots fired per
spot) by an auto execute-method, in a mass range between 1
and 20 kDa. Profiling spectra were calibrated using the protein
mixture Protein Calibration Standard I. All materials were
from Bruker Daltonics (Bremen, Germany).
Statistical  analysis:  Data  Obtained  from  MALDI-TOF
analyses were statistically analyzed with the ClinProTools 2.2
software  (Bruker  Daltonics),  and  all  spectra  were
systematically processed as follows: baseline subtraction was
performed by the Top Hat baseline algorithm to remove the
broad structures of the individual spectra, facilitating peak
selection  based  on  signal/noise  (S/N)  ratio  and  intensity
thresholds. All spectra were then normalized to their own
Total Ion Count (TIC) and recalibrated to correct possible
shifts due to the height profile of the preparation. From the
recalibrated preprocessed individual spectra, a total average
spectrum  was  calculated,  as  well  as  an  average  peak  list
representing all important peaks, which were used as features
to  determine  statistical  information.  Data  were  also
smoothened by the Savitsky Golay algorithm.
Data  representation:  Due  to  the  complexity  of  Mass
Spectrometry data, different tools have been employed to
facilitate data visualization and simplify their comprehension.
Thus, data were represented in a gel view format, directly
obtained from ClinProTools 2.2 software (Bruker Daltonics,
Bremen, Germany). In this type of representation, the x-axis
records the mass/charge (m/z) ratio, the y-axis displays the
running spectrum (each with four technical replicates) and the
peak intensity is expressed in arbitrary units (a.u.). In most
cases, an average spectrum of each class was also included at
the top of the gel view. This type of representation offers a
view of the profile obtained, giving an idea of the technique
reproducibility.
The statistical exploratory technique known as Principal
Component  Analysis  (PCA)  was  used  to  reduce  data
dimension,  diminishing  the  number  of  variables  to  a  few
principal components, containing the majority of variance.
This pattern recognition method characterizes or separates
studied samples into different clusters on the basis of their
similarities, representing the results on a plot.
RESULTS
Patients:  A  total  of  6  healthy  control  individuals  were
included in this study. Schirmer I test values were higher than
5 mm/min in all cases. Fluorescein staining according to the
Oxford Scale was grade 0 in all cases, and meibomian gland
status was normal in all control volunteers. According to the
modified OSD questionnaire, healthy subjects did not report
any symptom related to eye disorder, such as sensations of
burning, itching or grittiness in the eye, dryness, photophobia,
use of ocular lubricants or eye drops, eyelid flaking, blurred
vision, sleep, or sticky eyelids.
Solid-phase extraction (SPE) system selection: First one crude
tear preparation (1:10 water dilution) from patient CT5 was
analyzed  before  evaluating  the  different  SPE  methods  to
examine the general profile associated with the tear mass
spectrum.  The  obtained  spectra  indicated  strong  signal
suppression, possibly due to the high concentration of salts
and also lipids in tear (Figure 1A). However, when treated
with four different SPE methods (C8 and C18 Empore discs,
ZipTips and magnetic beads), the spectra showed a significant
increase in global quality, with a high abundance of peaks in
the peptide region up to 4 kDa and several masses up to 20 kDa
(Figure 1B). This result clearly demonstrates the necessity of
a pre-treatment for tear sample desalting and cleaning.
Additionally, to select the optimal system for sample
purification, 1 μl of tear from one patient (CT5) was purified
with the 4 different SPE systems (Empore C8, C18, ZipTips,
and  magnetic  beads).  After  purifying,  the  samples  were
analyzed by MALDI-TOF mass spectrometry under identical
experimental conditions. This assay was repeated four times
to evaluate the reproducibility of results. The peptide/protein
profiles of each one of these preparations were obtained using
ClinProTools 2.2 software (Figure 2). In general, a higher
number of peaks were observed in the lower range of the
spectra (below 4 kDa) with all the assayed methods. However,
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1574the pattern of peaks associated with C18 magnetic beads was
distinct  to  those  associated  with  the  Empore  and  ZipTip
methods. Thus, at a mass range <4 kDa, a higher resolution of
peaks was observed when using magnetic beads. Next, we
statistically determined the number of peaks provided by each
technique, as well as the weighted harmonic mean of their
coefficients of variation (CV%) in both the complete spectrum
window (1–20 kDa), and in three ranges of different masses:
1–4 kDa, 4–10 kDa, and 10–20 kDa. Results obtained in terms
of  sensitivity  (number  of  masses  detected),  and  peak
variations (intensity CV%) are summarized in Table 1. The
number  of  masses  detected  and  peak  intensity  variations
(%CV)  were  obtained  taking  into  account  four  technical
replica per individual within the same sample preparation
method, which subsequently were averaged.
When the total range is considered, both Empore disk
based  micro-columns  (C8  and  C18)  rendered  the  lowest
output, with only 84 and 81 peaks detected respectively, and
relatively  high  variations  in  intensity  (16  and  28%).  The
ZipTip based method provided an average of 102 masses with
a CV% of 15%. The best overall results were obtained with
the C18 magnetic beads, with the highest sensitivity (104
peaks) and the lowest CV% (11%).
Analysis of data spectra by PCA revealed that magnetic
beads  and  ZipTips  C18  rendered  a  good  homogeneity  in
results, grouping the samples in spatial proximity, whereas the
Empore Disks EM C8 and EM C18 systems presented a higher
dispersion of data suggesting low reproducibility as illustrated
in Figure 2B.
Magnetic bead batch reproducibility: Based on these SPE
results, C18 magnetic beads were selected and used for tear
sample purification. Because two different batches were to be
used for sample purification, a validation step was included
to test bead batch reproducibility and thus, to discard any
technical artifactual result on tear profile due magnetic bead
batch variability. To this end, 1 µl of tear sample from patients
CT1 and CT2 was processed with both batches (batches 1 and
2) from Bruker Daltonics, and analyzed by MS under exactly
the same conditions as detailed above.
The obtained profiles illustrated as virtual gels are shown
in  Figure  3A.  CT1  and  CT2  tear  profiles  showed  slight
differences in some peak intensities, due to inherent inter-
individual  variability.  However,  the  individual  profiles
resulting from processing with either batch 1 or 2 exhibited
high similarity among themselves, indicating reproducibility
of the assayed batches. Reproducibility was found not only in
peak numbers, but also in peak intensities, as can be seen in
the virtual gels.
To more objectively corroborate this observation, PCA
of the corresponding data was performed (Figure 3B). We
found that CT1 and CT2 tears were clearly distinguishable on
the  PCA  graph.  However  batch  1  and  2  data  for  each
individual were practically coincidental, indicating that the
profile resulting from treating the tear sample with batch 1 is
quite  similar  to  that  obtained  with  batch  2.  Thus,  no
differences  were  found  due  to  bead  batch,  thereby
corroborating  the  inter-batch  reproducibility  of  magnetic
beads.
Inter-day monitoring of tear profile: Six healthy volunteers
were monitored over 7 days to evaluate inter-day tear profile
variation. Tear samples were collected by the standard method
once  per  day  and  analyzed  by  MALDI-TOF  MS  after
purification. The resulting spectra exhibited an average of 96
peaks  with  a  signal/noise  ratio  above  5  in  a  mass  range
Figure  1.  Mass  spectrum  of  an
unprocessed tear and a tear processed
with  solid-phase  extraction  (SPE)
protocols. A: Direct analysis of a tear by
MALDI-TOF  MS  produced  a
displacement  of  the  baseline.  This
phenomenon is due to ion suppression
produced mainly by the presence of salts
and lipids. A limited peptide population
can be noted. B: The same tear treated
with four different SPE methods before
MS analysis offers a spectrum which is
more amenable for profiling analysis.
MB  C18:  Magnetic  Beads;  EM  C8:
Empore Disc C8; EM C18: Empore Disc
C18; ZT C18: Zip Tip.
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1575between 1 and 20 kDa. We found that there was no significant
variation in profiles of tears from the same patient (CT1) from
day one to day seven. Similar profiles were also obtained for
all other patients included in the study (Figure 4A), with only
slight differences in peak intensities being apparent.
Representation of these results by a PCA (Figure 4B)
revealed  spatial  proximity  of  samples  from  the  same
individual, indicating similarity in day-to-day tear profiles.
We also observed a slight differentiation in samples from
some  controls,  which  is  indicative  of  inter-individual
variability. No gender or age effects were observed on the
spectral profiles.
Tear  spectra  profiles  of  CT4  (days  3  and  4)  were
noticeably different to those obtained for the other monitored
days (Figure 4A). This odd behavior can be attributed to
technical variations during the processing of the samples, such
as  the  different  crystallization  of  the  matrix  over  the
Anchorchip  in  comparison  to  the  rest  of  the  spots.
Consequently, PCA showed this effect as an outlier, mainly
evident for day 3 which is completely separated from the
group (Indicated by an arrow in Figure 4B). In spite of this
shortcoming, neither the outliers, nor the replica have been
excluded from the analysis, to give more robustness to the
model.
Figure  2.  Proteome/peptidome  profile
gel  view  and  principal  component
analysis (PCA) of tear samples purified
with  four  different  solid-phase
extraction  (SPE)  methods.  A:  Virtual
gel, representing the mass/charge (m/z)
ratio (x-axis) of the detected peaks for
each  spectrum  acquired  (y-axis).  The
intensity of each peak is represented as
a  gray  intensity  scale  corresponding
virtually  to  the  z-axis.  In  this  gel
representation, the same tear pretreated
with four different SPE methods can be
observed:  Magnetic  Beads  (MB),
Empore Disc (EM) C8, Empore Disc
C18, and Zip Tip (ZT). In all the cases,
each tear was spotted in quadruplicate
(top  profile)  to  verify  the  technique
reproducibility  and  enhance  statistical
validity. B: PCA analysis showing that
those  samples  treated  with  column-
based systems (Empore C8 and C18)
group together with higher dispersion,
whereas  the  samples  treated  with
magnetic  beads  and  Zip  Tip  grouped
separately and homogeneously.
TABLE 1. TEAR SAMPLE PURIFICATION METHODS.
 
Zip tip Empore C8 Empore C18 Magnetic beads
Mass Range (kDa) peaks CV% peaks CV% peaks CV% peaks CV%
Total Spectra 102 14.93 84 15.96 81 28.04 104 11.00
Range 1; 1–4 55 14.37 52 16.14 49 34.74 73 9.25
Range 2: 4–10 36 15.85 20 14.78 24 20.62 20 24.92
Range 3: 10–20 11 14.96 12 16.25 8 25.49 11 19.87
        Comparison of the efficacy of the four purification methods for enrichment of tear samples based on solid phase extraction. CV
        %, coefficient of variation.
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1576Tear  film  bilaterality:  To  test  the  bilaterality  of  the  tear
profiles between right and left eye of the same subject, tears
were additionally collected by the standard method from 4
control individuals randomly selected (CT1, CT3, CT4, and
CT6) and subjected to MALDI-TOF MS analysis after sample
purification. Results were illustrated as virtual gels (Figure
5A) and a PCA plot (Figure 5B). In all four cases, gel views
indicated no significant differences between tears collected
from the left and right eyes, indicating bilaterality of tears in
healthy subjects. PCA confirmed this result, grouping samples
according to the individual (CT1, CT3, CT4, or CT6), but not
distinguishing tear source (left or right eye).
Effect of sample collection method on tear film profiles: To
evaluate if the sample collection method alters the outcome
of the tear film profile of control subjects, tear samples from
four volunteers CT1, CT3, CT4, and CT6 were collected from
the right eye by means of the eye-flush method, and from the
left eye without the addition of physiologic serum (standard
method). These were then analyzed under exactly the same
experimental conditions used for the rest of the samples in this
study. Gel view spectra presented in Figure 6A suggested that
similar  tear  film  profiles  are  independent  of  whether
physiologic  serum  was  added  or  not  for  tear  collection.
However, a lower intensity peak signal could be seen in some
profiles over 5 kDa with the eye-flush method. This weak peak
signal, caused by tear dilution due to the serum, was notable
principally in CT4, and also in profiles of CT3 (day 3) and
CT6 (day 2). Nevertheless, when the spectra were subjected
to PCA analysis, a clear association between samples from the
same  subject  was  observed,  independent  of  the  presence/
absence of physiologic serum for tear collection, suggesting
that despite weak intensities due to tear dilution, profiles were
essentially  maintained  in  the  eye-flush  tear  collection
technique (Figure 6B).
DISCUSSION
Proteins and peptides participate in the integrity and normal
functioning of the tear film, contributing to protective and
defensive  roles,  lubrication  of  the  ocular  surface  and
nourishing  of  the  cornea.  For  these  reasons,  the  study  of
peptides and light proteins has been gaining importance, since
these molecules may reveal novel biomarkers and targets for
therapy. Frequently, clinical trials find discrepancies which
may be due to the inclusion of heterogeneous individuals in a
specific  group.  This  heterogeneity  may  distort  results
producing outliers. In the present work using MALDI-TOF
Figure  3.  Batch  reproducibility  of
magnetic beads used in this study for
tear sample purification before MALDI-
TOF  MS  analysis.  A:  Virtual  gels
representing profiles from control (CT)
tear  samples  processed  with  two
different magnetic bead batches (1 and
2) from the same company. Tear profiles
were  obtained  after  separately
processing  1  µl  of  tear  sample  from
control individuals CT1 and CT2 with
both  batches.  The  same  number  and
intensities of peaks were observed in the
profiles  obtained  from  the  CT1  tear
sample treated with sphere batches 1 and
2. With tears from patient CT2, identical
results were also obtained using both
batches.  These  profile  similarities
indicate the reproducibility which can
be obtained using the two tested batches.
An  inherent  difference  in  peak
intensities  between  patient  CT1  and
CT2  was  observed  due  to  inter-
individual variability. B: The PCA plot
identifies  CT1  and  CT2  as  different
individuals,  which  are  spatially
separated.  However,  sample  from  the
same  individual  processed  with  bead
batches  1  (light  spheres)  and  2  (dark
spheres) from the same manufacturer,
are almost coincidental.
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1577MS, we have analyzed the tear profiles of healthy control
individuals, and the possible effect on variation of parameters
such  as  day-to-day  subject  variability,  individual
differentiation,  and  intrinsic  differences  in  tears  collected
from the left and right eye. In addition, we evaluated the effect
on profiling of physiologic serum addition for tear collection,
as in the eye-flush technique, in comparison to the standard
method of capillary-based collection.
Given the nature of the sample and the high sensitivity of
MALDI-TOF technology, we took special care to standardize
tear sample treatment for obtaining reproducible profiling
data. The use of native, non-purified tear samples is associated
with ion-suppression during MALDI-TOF analyses, due to
non-peptide or protein contaminants such as salts, lipids and
other  compounds  present  in  the  tear.  For  this  reason,
contaminants must be removed to better resolve the sample
by  MS.  A  wide  range  of  SPE  methods  with  different
chromatographic  techniques  is  currently  available  [15,25,
26]. Thus, we initially compared four different SPE methods
for MALDI-TOF peptide/protein tear profiling. Our findings
indicate  that  C18  magnetic  beads  are  better  suited  for
enrichment of tear samples in peptides and low molecular
weight proteins in the range of 1–20 kDa. Moreover, for
peptidome-oriented profiling studies of peptides up to 4 kDa,
this method is particularly interesting because of the high
number of peaks representing 70% of the total masses of the
spectra which are present within this window. This treatment
increased the quality of spectra, presenting an average of 96
peaks in a mass range between 1 and 20 kDa. These findings
are  corroborated  by  previous  studies  which  have
demonstrated  the  importance  of  human  tear  sample
preparation before peptide/protein profiling by MALDI-TOF
MS  analyses  [18,20,27],  and  the  enhancement  in  peak
detection that can be achieved when combinations with other
enrichment methods are performed [28].
Many  low-molecular  weight  proteins  and  peptides  in
human  tears  are  potentially  bioactive  proteins.  Using  the
technical approach which we report, it is possible to limit the
study of the tear to peptides and proteins in the range below
20 kDa, thereby including some abundant proteins, such as
lipocalin (17.5 kDa) and lysozyme (14 kDa), but discarding
other  abundant  proteins  such  as  lactoferrin  (90  kDa)  and
secretory  IgA  (385  kDa).  Additionally  it  would  also  be
possible to improve the study of other smaller low-abundance
proteins that might include promising biomarkers.
One of the reported disadvantages of magnetic beads for
sample purification is inter-batch variability (even between
batches from the same manufacturer), which can contribute to
increased variability in results [27,29]. For this reason, we
purified the same tear sample with two different magnetic
bead batches, and analyzed the resulting fractions by MALDI-
TOF MS. The results obtained indicated a high reproducibility
Figure  4.  Monitoring  of  normal  tear
samples  collected  during  seven
consecutive  days  (day  1-7)  from  6
control  volunteers  (CT1-CT6).  A:
Virtual  gel  views  representing  tear
profiles appear to be similar from the
first to the seventh day in each case. B:
Principal  Component  Analysis  (PCA)
of analyzed tear profiles. PCA analysis
confirmed  that  there  is  no  significant
variation of tear profiles from the same
individual, and revealed outlier samples
indicated by an arrow.
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1578between both batches, based on the number and intensity of
peaks of the spectrum as shown in Figure 3. The superposition
of profiles using PCA confirmed these results, and permitted
us to conclude that at least in the present study, the magnetic
bead  batches  used  for  sample  purification  give  rise  to
reproducible results. We could thus rule out the possibility that
variability in tear profiles might be due, at least in part, to bead
batch variability. This finding provides further evidence that
MALDI-TOF  coupled  with  magnetic  bead  enrichment  is
presently an adequate method for proteomic and peptidomic
profiling of tears.
The tear is a body fluid which is directly exposed to the
environment  and  subjected  to  possible  variations  in  its
composition, regulation and stability. It has been reported for
example that hormonal fluctuations, as well as circadian and
nycthemeral rhythms can alter the flow and/or composition of
the tear. Nycthemeral rhythms for example are responsible for
more abundant tear secretion during the day versus the night.
The brain limbic system also modifies basal tear secretion,
which is lower in states of fatigue, anxiety and somnolence
[30]. On the other hand, environmental factors such as air-
conditioned workplaces, and occupational factors associated
Figure 5. Analysis of tear film profile
bilaterality in four control individuals.
A:  Virtual  gel  view  of  tear  profiles
obtained  from  volunteers  CT1,  CT3,
CT4 and CT6 from left (LE) and right
eye (RE). B: PCA analysis of the same
tear profiles. An association and spatial
proximity of left and right tear samples
from the same individual is observed
indicating  similar  profiles.  A  spatial
separation  of  individuals  CT1,  CT3,
CT4,  and  CT6  is  also  observed
suggesting inter-individual variability.
Figure  6.  Effect  of  tear  collection
method on protein profiles. A: Gel view
of  tear  profiles  collected  from  CT1,
CT3,  CT4,  and  CT6  by  standard
capillary technique without addition of
physiologic serum (LE: S-, left eye), and
by the eye-flush technique involving the
addition of physiologic serum (RE: S+,
right eye). B: PCA representation of tear
protein profiles obtained from the same
individuals.  Left  eye  tears  were
collected  by  standard  capillary
technique (light spheres) and right eye
(dark  spheres)  by  the  addition  of
physiologic serum.
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1579with decreased blinking in workers who use video or computer
screens for long periods of time are factors which affect tear
stability and consequently may contribute to rather high inter-
individual variability in healthy control volunteers [31].
With a view to examining possible differences in the
peptide/protein profile of tears due to intrinsic and extrinsic
factors in healthy control volunteers, we analyzed fluctuations
in tear profiles over a period of 7 days. To this end, healthy
control volunteers were strictly selected in accordance with a
series of clinical parameters, and tear samples were obtained
under the same experimental conditions at the same time of
the day. We compared not only the daily variation in the
protein/peptide profiles of the tears of each individual during
this time, but also the grouping of all individuals together as
a hallmark of the homogeneity required in any control group.
Our results confirm the tear profile homogeneity as a group,
and also reveal the differences between the profiles of the
individuals (as presented in Figure 4B). This observation let
us to propose the use of such tear protein/peptide profiling
technique  for  clinical  trials  to  evaluate  homogeneity  of
participants and identification of possible outliers.
Additionally, we also examined variability between tears
from both eyes of a given individual, collected in the same
way. To this end, we evaluated 4 controls and comparatively
analyzed the profiles obtained for the right and left eyes. The
profiles obtained (Figure 5) for the left eye strongly resembled
those of its fellow eye, indicating that there are no significant
differences in the tear profiles of the left and right eyes from
the same control subject.
An issue which is currently unresolved is that of the most
appropriate  system  for  collecting  tear  samples.  In  1994,
Bjerrum and Prause [32] reported a method known as the
“flush”  tear  collection  technique  which  consisted  in  the
instillation of a drop of physiologic serum into the eye to
subsequently  obtain  the  tear.  Despite  presenting  clear
advantages  with  respect  to  other  systems,  particularly  in
pathologies, such as dry eye, in which tear volume is reduced,
it has been reported that the samples obtained with physiologic
serum present inter-day differences and a high variability in
tear protein levels [21]. For this reason, we evaluated the effect
of the addition of physiologic serum during tear collection on
tear protein profiles. To this end, once we had confirmed tear
bilaterality  in  4  healthy  volunteers,  we  performed  a
comparative analysis in which tear samples were obtained
from the same 4 patients during 4 days with the addition of
physiologic serum to the right eye (flush tears) and without
the addition of physiologic serum to the left eye (basal tears;
Figure 6). This analysis showed that the addition of serum
reduced in some cases the intensity of the peaks of the protein/
peptide profile, principally in the range >5 kDa. Taking into
account that sample purification was performed as a function
of tear volume and not as a function of the total protein present
in the tear, the observed signal reduction is surely due to the
effect of dilution associated with the physiologic serum. Since
the addition of serum varies the volume of the sample obtained
from different individuals, a different protein concentration is
obtained  in  the  final  volume  to  be  analyzed.  This  fact  is
responsible  for  a  large  variability  in  the  intensity  of  the
profiles,  not  only  between  different  individuals,  but  also
between tears from the same subject obtained on different
days. The variability is especially notorious in the case of the
CT4,  CT3,  and  CT6  controls,  thus  corroborating  the
observation of Ng et al. [21] who reported that physiologic
serum addition for the obtaining of tear samples induces inter-
day variability. Nevertheless, analysis of the profiles by PCA
(Figure 6B) reveals a clear differentiation between samples as
a function of the individual and not as a function of the tear
collection system employed. The prior normalization of the
intensities of each of the spectra by means of its own TIC
(Total Ion Count) makes the effect of dilution non-significant
when grouping samples with this type of tool.
Basal, reflex and flush tears from healthy non-contact
lens wearers were recently compared, in terms of total protein
content (TPC) and immunoglobulin A (IgA) concentrations,
and  the  overall  protein  profile  was  established  by  gel
electrophoresis (SDS–PAGE) and mass spectrometry (MS)
[22]. These authors found that flush tears were significantly
less concentrated than basal and reflex tears, and that the IgA
concentration  was  higher  in  basal  tears.  However,  the
percentage of IgA with respect to total protein content in flush
tears was not significantly different to that in basal tears. The
authors concluded that flush tears present essentially the same
spectrum of proteins in similar proportions, a finding which
is corroborated by the present study. Nevertheless, our results
additionally indicate that the tear-flush method can increase
inter-day variability.
The fact that the spectrum pattern is not significantly
altered by the tear-flush method may have special clinical
relevance,  since  the  addition  of  physiologic  serum  can
facilitate tear collection and minimize the time required. This
may be particularly relevant in pathological cases in which
patients present a very low volume of tear, often making it
impossible to obtain samples, as in the case of severe dry eye.
In these cases, the addition of a drop of physiologic serum
allows the obtaining of a manageable volume of sample for
analysis,  being  more  comfortable  for  the  patient  and  less
frustrating  and  time  consuming  for  the  researcher.
Nevertheless, particular attention should be paid to the inter-
day variability associated with the addition of physiologic
serum and to the validity of determinations in studies in which
a  determination  of  absolute  values  (as  concentration  of
proteins and peptides) is crucial.
In clinical studies involving tear samples, results are often
found which cannot be explained by the clinical profile of the
patient, deviating from the average behavior of the group.
Several factors related with patient (environmental stressors)
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account for much of these biases. On the other hand, rigor in
the methodology of sample processing is fundamental for
obtaining  reproducible  results.  For  example,  in  studies  of
profiling, the variables introduced during processing such as
making  aliquots,  working  temperature,  freeze-defreeze
cycles,  and  final  analysis  of  the  samples  contribute
enormously to variability in the results [13,29,33,34]. In the
present study, we have rigorously controlled these variables
during the study.
In conclusion, this study demonstrates that MALDI-TOF
MS  coupled  with  C18  magnetic  beads  is  a  suitable
methodology for tear profiling studies. The tear peptide and
protein profiles which we obtained for control individuals
testify to the absence of inter-day variability in samples from
the same individual. In contrast, it is possible to observe inter-
individual variability within the same control group. This
facilitates the detection of potential outliers within a study
which may lead to the distortion of results. Profiling analysis
confirms the bilaterality of the tear from both eyes of the same
individual, at least in healthy control individuals. Finally, we
have shown that the effect of using the eye-flush method on
the protein/peptide profile is not significant in terms of the
number  of  resolved  peaks;  however,  this  method  does
significantly affect the intensity of the spectrum peaks and
variability.  The  present  study  lays  the  foundation  for
subsequent studies involving tear analysis, not only in control
individuals,  but  also  in  patients  with  pathologies  which
influence the tear.
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